Epstein-Barr Virus, Epigenetics, and Cancer
Welcome to the TEMPERA LAB
We are located in the Fels Institute for Cancer Research and Molecular Biology at the Lewis Katz School of Medicine – Temple University. We pursue two lines of research: one focus is on how chromatin can regulate the complex and dynamic gene expression patterns adopted by the oncovirus Epstein-Barr Virus (EBV) during persistence infection; a second focus is on an important family of polymerases, the poly-ADP ribose polymerases (PARPs), which regulate functions like DNA repair, genomic stability, and apoptosis.
We utilize our expertise in chromatin immunoprecipitation, Chromatin Conformation Capture (3C) assay, and genome-wide data analysis to better understand the link between three-dimensional structure of chromosome, chromatin composition and gene expression during EBV latency and PARP activation. We aim in the long run to identify new cellular functions regulated by EBV and PARP1 that can be targeted by epigenetic drugs and to provide novel therapeutic approaches for treating EBV+ cancer. Learn more
March 2019 We submitted our abstracts about different ways epigenetic modifications regulate EBV latency. See you at the IHW2019 in Knoxville.
February 2019 Our recent work about the role of PARP1 in LMP1-driven gene expression has been featured on Science Trends
November 2018 The paper from our collaborator Dr. Maria D’Erme, at the Department of Biochemical Science of Rome University “La Sapienza”, is now available on the Biochemical Pharmacology journal
November 2018 Our work connecting PARP1 activity with LMP1-driven gene expression and alteration of cellular metabolism is now available on the PLOS Pathogens website.